background
impact
annual
influenza
epidem
prevail
strain
vari
worldwid
region
major
vaccin
use
contain
two
influenza
strain
one
influenza
b
strain
trival
vaccin
aim
aim
studi
compar
laboratori
confirm
influenza
b
case
three
consecut
year
respect
vaccin
histori
clinic
symptom
molecular
virolog
method
partial
ha
gene
sequenc
analyz
lineag
determin
complet
ha
sequenc
case
report
vaccin
fatal
case
clinic
data
retriev
patient
chart
find
season
influenza
b
case
retriev
frequenc
yamagatalineag
strain
increas
differ
detect
rel
frequenc
comorbid
season
adult
patient
pediatr
patient
vaccin
influenza
interpret
phylogenet
yamagata
strain
cluster
similarli
compar
previou
two
influenza
season
rel
frequenc
influenza
b
case
differ
clinic
symptom
remain
similar
conclus
world
health
organ
recommend
use
tetraval
vaccin
contain
two
influenza
b
strain
yamagata
victoria
addit
two
influenza
strain
implement
nation
vaccin
guidelin
influenza
b
viru
orthomyxovirida
famili
segment
singl
strand
neg
sens
rna
genom
first
isol
influenza
b
viru
diverg
two
lineag
victoria
yamagata
late
similar
clinic
differ
phylodynam
properti
although
infect
pig
seal
observ
known
anim
reservoir
influenza
b
thu
influenza
infect
zoonot
influenza
b
viru
circul
human
popul
narrow
host
rang
slower
evolut
thought
main
contribut
factor
less
frequent
occurr
influenza
b
epidem
influenza
b
predomin
report
countri
throughout
northern
hemispher
lead
influenza
type
europ
canada
second
common
type
influenza
usa
germani
season
fourth
season
centuri
domin
influenza
b
prevail
lineag
influenza
b
chang
frequent
world
health
organ
recommend
includ
lineag
tetraval
vaccin
key
compon
vaccin
viral
hemagglutinin
ha
cover
viral
surfac
trimer
form
major
antigen
region
locat
subunit
form
globular
head
domain
respons
recognit
bind
sialic
acid
surfac
target
cell
subunit
main
compon
ha
stalk
although
antibodi
vaccin
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
c
l
c
e
v
c
c
n
e
cross
reactiv
observ
vaccin
effici
two
lineag
might
reduc
season
formul
trival
influenza
vaccin
match
circul
strain
due
antigen
differ
addit
grow
evid
vaccin
effect
alreadi
wane
within
season
thu
reduc
immunolog
protect
even
vaccin
contain
match
strain
previou
season
aim
studi
analyz
clinic
molecular
featur
laboratoryconfirm
influenza
b
case
three
consecut
season
comparison
patient
characterist
done
relat
combin
season
appropri
addit
molecular
epidemiolog
viral
hemagglutinin
ha
gene
perform
select
isol
amino
acid
chang
map
major
antigen
domain
ha
protein
specimen
clinic
data
respiratori
sampl
includ
nasal
aspir
supernat
nasal
pharyng
swab
throat
rins
fluid
tracheal
secret
bronchoalveolar
lavag
fluid
patient
test
respiratori
viru
infect
test
initi
discret
lineag
determin
na
sequenc
bplong
amplicon
ha
gene
assess
bigdy
termin
sequenc
kit
abi
genet
analyz
appli
biosystem
foster
citi
usa
sequenc
region
correspond
nucleotid
posit
complet
ha
gene
victoria
lineag
yamagata
lineag
respect
sequenc
nucleotid
belong
victorialineag
virus
nucleotid
belong
yamagatalineag
phylogenet
analysi
na
sequenc
complet
ha
perform
accord
guidanc
case
low
influenza
b
concentr
altern
protocol
gener
three
instead
two
overlap
fragment
use
phylogenet
tree
nucleotid
larg
ha
code
region
construct
nucleotid
level
mega
softwar
version
use
maximumlikelihood
method
bootstrap
analysi
perform
replic
complet
ha
sequenc
submit
genbank
access
number
statist
analysi
statist
analysi
perform
use
ibm
spss
statist
window
version
armonk
ny
ibm
corp
continu
valu
express
mean
median
rang
categor
data
frequenc
percentag
student
ttest
mannwhitney
u
test
perform
compar
mean
chisquar
fisher
exact
test
perform
categor
variabl
test
twotail
plevel
consid
signific
rel
absolut
number
influenza
type
detect
shown
tabl
season
maximum
number
case
occur
week
peak
occurr
patient
year
week
week
adult
patient
fig
eleven
case
season
occur
tabl
studi
popul
clinic
featur
influenza
b
infect
case
tabl
pediatr
patient
signific
differ
season
except
combin
rate
comorbid
risk
factor
sever
cours
influenza
howev
could
attribut
singl
analyz
factor
look
adult
popul
signific
differ
season
previou
season
except
higher
proport
femal
patient
lower
proport
viral
coinfect
differ
note
age
group
adult
patient
vaccin
mostli
trival
vaccin
wherea
pediatr
patient
unvaccin
rate
comorbid
significantli
higher
adult
popul
furthermor
clinic
cours
diseas
sever
adult
popul
higher
rate
icu
admiss
invas
ventil
fatal
outcom
observ
ha
phylogeni
sequenc
analysi
whole
hemagglutinin
gene
perform
victoria
yamagata
strain
consist
confirm
result
initi
lineag
determin
includ
strain
patient
known
trival
n
tetraval
n
vaccin
randomli
select
patient
without
known
vaccin
n
patient
fatal
outcom
within
day
influenza
b
detect
n
except
one
strain
victoria
strain
origin
season
belong
clade
strain
phylogenet
close
relat
cluster
base
vaccin
histori
fatal
outcom
fig
analyz
yamagata
strain
belong
clade
strain
phylogenet
close
relat
strain
phylogeni
indic
discret
drift
season
season
cluster
regard
vaccin
histori
fatal
outcom
observ
fig
amino
acid
chang
detect
amino
acid
chang
aachang
within
ha
protein
depict
tabl
influenza
season
domin
yamagatalineag
influenza
b
europ
germani
largest
season
term
case
number
sinc
establish
nationwid
surveil
system
larg
scale
epidem
pandem
usual
caus
influenza
attribut
mostli
broader
host
rang
faster
rate
evolut
influenza
influenza
b
infect
usual
occur
tempor
delay
toward
end
influenza
adomin
season
except
impact
influenza
b
infect
regard
public
health
therefor
surpris
howev
season
high
proport
influenza
b
infect
occur
infrequ
specif
germani
mild
season
sever
season
domin
influenza
b
share
influenza
case
high
sever
season
overal
estim
million
excess
consult
germani
may
attribut
sever
factor
accord
ecdc
influenza
season
start
earlier
previou
one
true
epidem
phase
two
influenza
b
heavi
season
studi
time
frame
isol
case
compar
season
epidem
phase
start
week
last
week
epidem
threshold
cross
week
week
anoth
factor
contribut
sever
season
might
patient
popul
attack
rate
rel
ill
ratio
influenza
b
highest
children
decreas
age
howev
major
differ
seen
season
higher
proport
adult
patient
agesubgroup
pediatr
patient
adult
patient
differ
clinic
characterist
two
previou
season
howev
adult
popul
seen
high
proport
comorbid
risk
factor
might
contribut
fig
continu
sever
outcom
influenza
diseas
known
exampl
cardiac
insuffici
addit
age
shift
toward
adult
popul
thu
increas
impact
public
health
system
may
explain
sever
season
high
number
excess
consult
interpret
present
clinic
data
howev
need
done
caution
may
bia
toward
sever
diseas
cours
hospit
set
fatal
rate
adult
popul
studi
thu
transfer
gener
popul
third
potenti
factor
may
circul
influenza
type
yamagatalineag
influenza
b
predominantli
found
season
contrast
victoria
lineag
faster
evolut
nearli
season
repres
phylogenet
bottleneck
biolog
yamagata
lineag
differ
long
term
studi
ha
yamagata
lineag
long
cocircul
yamagata
variant
observ
accord
observ
analyz
strain
studi
phylogenet
close
relat
furthermor
detect
amino
acid
chang
scatter
throughout
ha
best
knowledg
substitut
known
increas
viru
pathogen
sinc
chang
antigen
site
dominantli
locat
region
indic
main
target
immun
pressur
regard
vaccin
strain
main
antigen
region
affect
strain
occur
mainli
region
follow
region
analyz
yamagata
strain
contrast
analyz
victoria
strain
least
one
amino
acid
chang
region
regard
vaccin
strain
therefor
surpris
yamagatalineag
circul
popul
three
consecut
season
abl
caus
major
epidem
tabl
amino
acid
chang
victoriaand
yamagatastrain
regard
respect
vaccin
strain
amino
acid
number
regard
protein
well
subunit
indic
vaccin
strain
isol
compar
given
red
lineag
isol
studi
label
vaccin
trival
vaccin
triangl
vaccin
tetraval
vaccin
squar
randomli
select
case
without
vaccin
histori
circl
fatal
case
black
fill
symbol
symbol
repres
main
antigen
site
amino
acid
b
amino
acid
c
amino
acid
amino
acid
yamagatalineag
strain
ident
amino
acid
level
depict
pool
contain
patient
follow
characterist
reason
might
interplay
circul
influenza
strain
caus
infect
choic
vaccin
compon
type
vaccin
season
influenza
victorialineag
influenza
b
caus
major
influenza
infect
influenza
main
caus
flu
diseas
look
influenza
b
compon
broadli
use
trival
influenza
vaccin
switch
yamagatalineag
b
victorialineag
season
effect
caus
mismatch
three
studi
season
strain
immunolog
cover
recent
epidem
current
vaccin
composit
influenza
b
yamagatalineag
increas
proport
nonimmun
individu
adult
popul
thu
may
contribut
observ
shift
age
distribut
infect
patient
crossreact
antibodi
isol
vaccin
individu
contribut
immun
influenza
b
well
defin
degre
lineag
crossprotect
report
upon
vaccin
trival
influenza
viru
vaccin
howev
seem
limit
certain
age
group
vaccin
efficaci
consist
superior
influenza
b
strain
belong
vaccin
lineag
capabl
individu
gener
broad
antibodi
respons
epitop
includ
region
conserv
two
lineag
eg
ha
stalk
seem
major
import
thu
factor
influenc
lineag
crossprotect
complex
easi
predict
also
immun
memori
may
substanti
impact
target
epitop
patient
vaccin
histori
studi
trival
vaccin
expect
moder
level
vaccin
effici
use
major
vaccin
patient
adult
howev
major
improv
influenza
diseas
burden
may
accomplish
extend
vaccin
recommend
younger
age
group
immunolog
thu
suscept
infect
recommend
use
tetraval
vaccin
contain
two
influenza
b
strain
yamagata
victoria
addit
two
influenza
strain
implement
nation
vaccin
guidelin
done
germani
result
sever
influenza
season
